Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open | $0.96 |
Close | $0.93 |
Volume / Avg. | 583.29K / 200.83K |
Day Range | $0.92 - $0.97 |
52 Wk Range | 0.65 - 2.12 |
Market Cap | $72.20M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 0.26% |
Days to Cover | 1.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Clearside Biomedical (NASDAQ:CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Rani Therapeutics Hldgs (NASDAQ:RANI).
Clearside Biomedical has a consensus price target of $5.22.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.9659 last updated September 5, 2024 at 6:24 PM EDT.
There are no upcoming dividends for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.